U.S. FDA guidance on biosimilars may be imminent By: Reuters: Company News September 23, 2011 at 14:50 PM EDT * Long-awaited rules may pave way for U.S. biosimilar market Read More >> Related Stocks: Amgen Biogen Idec Merck & Co Momenta Pharma Noront Resources Ltd Novartis Ag ADR Pfizer